Patents by Inventor Bernard Delaey

Bernard Delaey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions of cell lysate and processes for the production and use thereof
    Patent number: 7264826
    Abstract: The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: September 4, 2007
    Assignee: CellTran Limited
    Inventors: Chris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
  • Pharmaceutical compositions of cell lysate and processes for the production and use thereof
    Publication number: 20060039989
    Abstract: The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
    Type: Application
    Filed: November 25, 2003
    Publication date: February 23, 2006
    Applicant: Innogenetics N.V.
    Inventors: Chris Vervaet, Jean-Paul Remon, Bernard Delaey, Peter De Waele
  • Wound healing compositions and uses
    Publication number: 20050079147
    Abstract: The present invention relates to poloxamer compositions and the use thereof for the purpose of treating skin wounds on a human body.
    Type: Application
    Filed: December 23, 2003
    Publication date: April 14, 2005
    Inventors: Bernard Delaey, Peter De Waele
  • Medicaments based on polymers composed of methacrylamide-modified gelatin
    Patent number: 6458386
    Abstract: The present invention relates to a composition comprising a biopolymer matrix comprising cross-linked vinyl-derivatives of gelatin, or co-polymerized methacrylamide modified gelatin with vinyl-modified polysaccharides, or cross-linked vinyl-substituted polysaccharide and gelatin being physically entrapped in a semi-interpenetrating network. Preferably said polysaccharide comprises dextran or xanthan. The present invention also relates to a wound dressing or a controlled release device comprising said biopolymer matrix. Preferably said matrix is in the form of a hydrated film, a hydrated or dry foam, dry fibers which may be fabricated into a woven or non-woven tissue, hydrated or dry microbeads, dry powder, or covered with a semipermeable film so as to control the humidity of the wound covered with the dressing, with the permeability chosen so as to maintain this humidity within a therapeutically optimal window.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: October 1, 2002
    Assignee: Innogenetics N.V.
    Inventors: Etienne Schacht, An Van Den Bulcke, Bernard Delaey, Jean-Pierre Draye
  • Form of amphiregulin, methods for producing and using the same and compositions comprising the same
    Patent number: 6204359
    Abstract: An isolated and purified polypeptide having heparin binding properties with the amino acid sequence of SQ ID No: 1 and pharmaceutical compositions for treating skin wounds.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: March 20, 2001
    Assignee: Innogenetics N.V.
    Inventors: Bernard Delaey, Jos Raymackers, Hugo Van Heuverswyn
  • Medicaments containing gelatin cross-linked with oxidized polysaccharides
    Patent number: 6132759
    Abstract: The present invention relates to a wound dressing comprising a biopolymer matrix comprising gelatin cross-linked with an oxidized polysaccharide. Preferably said oxidized polysaccharide comprises an oxidized dextran or an oxidized xanthan. Preferably said matrix is in the form of a hydrated film, a hydrated or dry foam, dry fibers which may be fabricated into a woven or non-woven tissue, hydrated or dry microbeads, dry powder; or said matrix is covered with a semipermeable film, so as to control the humidity of the wound covered with the dressing, with the permeability chosen so as to maintain this humidity within a therapeutically optimal window. A polysulfated polysaccharide with a M.W. greater than 30,000 kDa is mechanically entrapped during the formation of said matrix.
    Type: Grant
    Filed: October 27, 1998
    Date of Patent: October 17, 2000
    Assignee: Innogenetics N.V.
    Inventors: Etienne Schacht, Jean Pierre Draye, Bernard Delaey